KENILWORTH, N.J.–(BUSINESS WIRE)–RDx BioScience (RDx) calls for increased use of genetic testing to identify mutations in BRCA1 and BRCA2, …
Read More »FDA Expands Approval of Genmab, Novartis’ Arzerra in CLL
Copenhagen, Denmark; August 31, 2016 — Genmab A/S (Nasdaq Copenhagen: GEN) announced today that the …
Read More »